Clinicopathological study of surgically treated non-neoplastic diseases of the pancreas with special reference to autoimmune pancreatitis.

Autoimmune pancreatitis (AIP) Endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) Immunoglobulin G4 (IgG4) staining Surgical treatment Tumor-forming chronic pancreatitis (TFCP)

Journal

Langenbeck's archives of surgery
ISSN: 1435-2451
Titre abrégé: Langenbecks Arch Surg
Pays: Germany
ID NLM: 9808285

Informations de publication

Date de publication:
04 Jun 2023
Historique:
received: 14 09 2022
accepted: 14 05 2023
medline: 5 6 2023
pubmed: 4 6 2023
entrez: 3 6 2023
Statut: epublish

Résumé

After the popularization of serum immunoglobulin G4 (IgG4) measurement and endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) in our institute, surgical resection for non-neoplastic diseases of the pancreas became less common. Although the incidence of such false-positive cases was clarified in the 10-year period after the introduction of these measures (2009-2018), these data were not compared with the 30 years before 2009 (1979-2008). This study was performed to determine the percentage of autoimmune pancreatitis (AIP) that was included during the latter period and how the numbers of false-positive cases differed between the two periods. From 1979 to 2008, 51 patients had clinical suspicion of pancreatic carcinoma (false-positive disease). Among these 51 patients, 32 non-alcoholic patients who had tumor-forming chronic pancreatitis (TFCP) were clinically, histologically, and immunohistochemically compared with 11 patients who had TFCP during the latter 10-year period. Retrospective IgG4 immunostaining of false-positive TFCP revealed 14 (35.0%) cases of AIP in the former 30 years versus 5 (45.5%) in the latter 10 years. There were 40 (5.9%) cases of TFCP among 675 patients in the former 30 years and 11 (0.9%) among 1289 patients in the latter 10 years. When the TFCP ratio of pancreatic resections and the AIP ratio of false-positive TFCPs were compared between the two periods, the TFCP ratio was 5.9% versus 0.9% and the AIP ratio was 35.0% versus 45.5%, respectively. It can thus be speculated that IgG4 measurement and EUS-FNA are absolutely imperative for the diagnosis of TFCP.

Identifiants

pubmed: 37270454
doi: 10.1007/s00423-023-02944-y
pii: 10.1007/s00423-023-02944-y
doi:

Substances chimiques

Immunoglobulin G 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

223

Informations de copyright

© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Références

Hamano H, Kawa S, Horiuchi A, Unno H, Furuya N, Akamatsu T, Fukushima M, Nikaido T, Nakayama K, Usuda N, Kiyosawa K (2001) High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med 344:732–738
doi: 10.1056/NEJM200103083441005 pubmed: 11236777
Vilmann P, Jacobsen GK, Henriksen FW, Hancke S (1992) Endoscopic ultrasonography with guided fine needle aspiration biopsy in pancreatic disease. Gastrointest Endosc 38:172–173
doi: 10.1016/S0016-5107(92)70385-X pubmed: 1568614
Yamao K, Sawaki A, Mizuno N, Shimizu Y, Yatabe Y, Koshikawa T (2005) Endoscopic ultrasound-guided fine-needle aspiration biopsy (EUS-FNAB): past, present, and future. J Gastroenterol 40:1013–1023
doi: 10.1007/s00535-005-1717-6 pubmed: 16322944
Hoki N, Mizuno N, Sawaki A, Tajika M, Takayama R, Shimizu Y, Bhatia V, Yamao K (2009) Diagnosis of autoimmune pancreatitis using endoscopic ultrasonography. J Gastroenterol 44:154–159
doi: 10.1007/s00535-008-2294-2 pubmed: 19214678
Chari ST (2007) Diagnosis of autoimmune pancreatitis using its five cardinal features: introducing the Mayo Clinic’s HISORt criteria. J Gastroenterol 42(Suppl 18):39–41
doi: 10.1007/s00535-007-2046-8 pubmed: 17520222
Shimosegawa T, Chari ST, Frulloni L, Kamisawa T, Kawa S, Mino-Kenudson M, Kim M-H, Kloeppel G, Lerch MM, Loehr M, Notohara K, Okazaki K, Schneider A, Zhang L (2011) International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the international association of pancreatology. Pancreas 40:352–358
doi: 10.1097/MPA.0b013e3182142fd2 pubmed: 21412117
Otsuki M, Chung JB, Okazaki K, Kim M-H, Kamisawa T, Kawa S, Park SW, Shimosegawa T, Lee K, Ito T, Nishimori I, Notohara K, Naruse S, Ko SBH, Kihara Y (2008) Asian diagnostic criteria for autoimmune pancreatitis: consensus of the Japan-Korea Symposium on Autoimmune Pancreatitis. J Gastroenterol 43:403–408
doi: 10.1007/s00535-008-2205-6 pubmed: 18600383
van Gulik TM, Reeders JWAJ, Bosma A, Smits TMMNJ, Allema JH, Rauws EAJ, Offerhaus GJA, Obertop H, Gouma DJ (1997) Incidence and clinical findings of benign, inflammatory disease in patients resected for presumed pancreatic head cancer. Gastrointest Endosc 46:417–423
doi: 10.1016/S0016-5107(97)70034-8 pubmed: 9402115
Weber SM, Cubukcu-Dimopulo O, Palesty FA, Suriawinata A, Klimstra D, Brennan MF, Conlon K (2003) Lymphoplasmacytic sclerosing pancreatitis: inflammatory mimic of pancreatic carcinoma. J Gastrointest Surg 7:129–139
doi: 10.1016/S1091-255X(02)00148-8 pubmed: 12559194
Abraham SC, Wilentz RE, Yeo CJ, Sohn TA, Cameron JL, Boitnott JK, Hruban RH (2003) Pancreaticoduodenectomy (Whipple resections) in patients without malignancy. Am J Surg Pathol 27:110–120
doi: 10.1097/00000478-200301000-00012 pubmed: 12502933
Kawaguchi K, Koike M, Tsuruta K, Okamoto A, Tabata I, Fujita N (1991) Lymphoplasmacytic sclerosing pancreatitis with cholangitis: a variant of primary sclerosing cholangitis extensively involving pancreas. Hum Pathol 22:387–395
doi: 10.1016/0046-8177(91)90087-6 pubmed: 2050373
Sarles H, Sarles JC, Maratore R, Guien C (1961) Chronic inflammatory sclerosis of the pancreas: an autonomous pancreatic disease? Am J Dig Dis 6:688–698
doi: 10.1007/BF02232341 pubmed: 13746542
Yoshida K, Toki F, Takeuchi T, Watanabe S, Shiratori K, Hayashi N (1995) Chronic pancreatitis caused by an autoimmune abnormality: proposal of the concept of autoimmune pancreatitis. Dig Dis Sci 40:1561–1568
doi: 10.1007/BF02285209 pubmed: 7628283
Zamboni G, Luettges J, Capelli P, Frulloni L, Cavallini G, Pederzoli P, Leins A, Longnecker D, Kloeppel G (2004) Histopathological features of diagnostic and clinical relevance in autoimmune pancreatitis: a study on 53 resection specimens and 9 biopsy specimens. Virchows Arch 445:552–563
doi: 10.1007/s00428-004-1140-z pubmed: 15517359
Kobayashi G, Fujita N, Noda Y, Ito K, Horaguchi J, Takasawa O, Obana T, Nakahara K, Uzuki M, Sawai T (2007) Lymphoplasmacytic sclerosing pancreatitis forming a localized mass: a variant form of autoimmune pancreatitis. J Gastroenterol 42:650–656
doi: 10.1007/s00535-007-2068-2 pubmed: 17701128
van Heerde MJ, Biermann K, Zondervan PE, Kazemier G, van Eijck CHJ, Pek C, Kuipers EJ, van Buuren HR (2012) Prevalence of autoimmune pancreatitis and other benign disorders in pancreatoduodenectomy for presumed malignancy of the pancreatic head. Dig Dis Sci 57:2458–2465
doi: 10.1007/s10620-012-2191-7 pubmed: 22588243 pmcid: 3428528
Raety S, Sand J, Nordback I, Rinta-Kiikka I, Vasama K, Hagstroem J, Nordling S, Siren J, Kiviluoto T, Haglund C (2015) Tumor-like chronic pancreatitis is often autoimmune pancreatitis. Anticancer Res 35:6163–6166
Learn PA, Grossman EB, Do RKG, Allen PJ, Brennan MF, D’Angelica MI, DeMatteo RP, Fong Y, Klimstra DS, Schattner MA, Jarnagin WR (2011) Pitfalls in avoiding operation for autoimmune pancreatitis. Surgery 150:968–974
doi: 10.1016/j.surg.2011.06.015 pubmed: 21893326
Lopez-Serrano A, Crespo J, Pascual I, Salord S, Bolado F, del-Pozo-Garcia AJ, Ilzarbe L, de-Madaria E, Moreno-Osset E (2016) Diagnosis, treatment, and long-term outcomes of autoimmune pancreatitis in Spain based on the International Consensus Diagnostic Criteria: a multi-centre study. Pancreatology 16:382–390
doi: 10.1016/j.pan.2016.02.006 pubmed: 26944001
Dickerson LD, Farooq A, Bano F, Kleeff J, Baron R, Raraty M, Ghaneh P, Sutton R, Whelan P, Campbell F, Healey P, Neoptolemos JP, Yip VS (2019) Differentiation of autoimmune pancreatitis from pancreatic cancer remains challenging. World J Surg 43:1604–1611
doi: 10.1007/s00268-019-04928-w pubmed: 30815742
Mizuno N, Bhatia V, Hosoda W, Sawaki A, Hoki N, Hara K, Takagi T, Ko SBH, Yatabe Y, Goto H, Yamao K (2009) Histological diagnosis of autoimmune pancreatitis using EUS-guided trucut biopsy: a comparison study with EUS-FNA. J Gastroenterol 44:742–750
doi: 10.1007/s00535-009-0062-6 pubmed: 19434362
Haba S, Yamao K, Bhatia V, Mizuno N, Hara K, Hijioka S, Imaoka H, Niwa Y, Tajika M, Kondo S, Tanaka T, Shimizu Y, Yatabe Y, Hosoda W, Kawakami H, Sakamoto N (2013) Diagnostic ability and factors affecting accuracy of endoscopic ultrasound-guided fine needle aspiration for pancreatic solid lesions: Japanese large single center experience. J Gastroenterol 48:973–981
doi: 10.1007/s00535-012-0695-8 pubmed: 23090002

Auteurs

Makoto Seki (M)

Departments of Hepato-Biliary-Pancreatic Surgery, Cancer Institute of the Japanese Foundation for Cancer Research, 3-10-6 Ariake, Koto-Ku, Tokyo, 135-8558, Japan. mc-seki@m-eijyukai.or.jp.
Department of Surgery, Mitaka Central Hospital, 5-23-10, Kami-Renjaku, Mitaka City, Tokyo, 181-0012, Japan. mc-seki@m-eijyukai.or.jp.

Eiji Ninomiya (E)

Department of Endoscopy, Kasumigaseki Building Clinic, 3-5-2-2F, Kasumigaseki, Chiyoda-Ku, Tokyo, 100-6012, Japan.

Akio Saiura (A)

Departments of Hepato-Biliary-Pancreatic Surgery, Cancer Institute of the Japanese Foundation for Cancer Research, 3-10-6 Ariake, Koto-Ku, Tokyo, 135-8558, Japan.
Department of Hepato-Biliary-Pancreatic Surgery, Juntendo University Hospital, 2-1-1, Hongo, Bunkyo-Ku, Tokyo, 113-0033, Japan.

Yu Takahashi (Y)

Departments of Hepato-Biliary-Pancreatic Surgery, Cancer Institute of the Japanese Foundation for Cancer Research, 3-10-6 Ariake, Koto-Ku, Tokyo, 135-8558, Japan.

Yosuke Inoue (Y)

Departments of Hepato-Biliary-Pancreatic Surgery, Cancer Institute of the Japanese Foundation for Cancer Research, 3-10-6 Ariake, Koto-Ku, Tokyo, 135-8558, Japan.

Masamichi Katori (M)

Departments of Pathology, Cancer Institute of the Japanese Foundation for Cancer Research, 3-10-6 Ariake, Koto-Ku, Tokyo, 135-8558, Japan.

Noriko Yamamoto (N)

Departments of Pathology, Cancer Institute of the Japanese Foundation for Cancer Research, 3-10-6 Ariake, Koto-Ku, Tokyo, 135-8558, Japan.

Manabu Takamatsu (M)

Departments of Pathology, Cancer Institute of the Japanese Foundation for Cancer Research, 3-10-6 Ariake, Koto-Ku, Tokyo, 135-8558, Japan.

Yo Kato (Y)

Departments of Pathology, Cancer Institute of the Japanese Foundation for Cancer Research, 3-10-6 Ariake, Koto-Ku, Tokyo, 135-8558, Japan.

Keiko Yamada (K)

Departments of Diagnostic Radiology, Cancer Institute of the Japanese Foundation for Cancer Research, 3-10-6 Ariake, Koto-Ku, Tokyo, 135-8558, Japan.

Kiyoshi Matsueda (K)

Departments of Diagnostic Radiology, Cancer Institute of the Japanese Foundation for Cancer Research, 3-10-6 Ariake, Koto-Ku, Tokyo, 135-8558, Japan.

Yasuo Ohkura (Y)

Department of Pathology, Kyorin University School of Medicine, 6-20-2 Shinkawa, Mitaka City, Tokyo, 181-8618, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH